ProfileGDS4132 / 1564691_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 31% 32% 37% 33% 32% 29% 34% 30% 28% 30% 28% 28% 32% 33% 42% 27% 33% 32% 31% 32% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10177.239531
GSM201543Muscle PCOS pioglitazone 12170.964332
GSM201544Muscle PCOS pioglitazone 16195.796537
GSM201545Muscle PCOS pioglitazone 20191.90733
GSM201829Muscle PCOS pioglitazone 23185.48432
GSM201830Muscle PCOS pioglitazon 25173.516529
GSM201831Muscle PCOS pioglitazone 27185.274634
GSM201832Muscle PCOS pioglitazone 3173.306930
GSM201833Muscle PCOS pioglitazone 4164.016928
GSM201834Muscle PCOS pioglitazone 8170.803630
GSM201835Muscle PCOS after pioglitazone 10254.721528
GSM201836Muscle PCOS after pioglitazone 12257.695928
GSM201837Muscle PCOS after pioglitazone 16265.881632
GSM201838Muscle PCOS after pioglitazone 20274.144233
GSM201839Muscle PCOS after pioglitazone 232102.00742
GSM201840Muscle PCOS after pioglitazone 25262.269727
GSM201841Muscle PCOS after pioglitazone 27267.630233
GSM201842Muscle PCOS after pioglitazone 3263.749432
GSM201843Muscle PCOS after pioglitazone 4275.544731
GSM201844Muscle PCOS after pioglitazone 8273.289832